Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r1 or r2 resection (with or without neoadjuvant therapy) with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)
This is the 2010 version of HCPCS G9101 - please refer to the 2016 HCPCS code set for the latest version.
Added on Sunday, January 01, 2006
Status changed on Monday, January 01, 2007 to: No maintenance for this code